![]() U-M alum Caroline Sisson had also received the J&J vaccine before the recall and said ultimately, she was happy she received the vaccine. “From what I read, it seemed like for other vaccines, something like this probably wouldn’t have forced a recall just because it was such a small percentage of people that got blood clots.” “There’s literally so many more blood clots that happen from taking birth control than there were from the vaccination,” Rogoff said. The risk of developing TTS after receiving the J&J vaccine is significantly lower than the blood clots occasionally caused by birth control. She mentioned her experience with using birth control, which the FDA states has between a 0.09% and 0.3% chance of causing blood clots. LSA sophomore Sophie Rogoff received the J&J vaccine prior to the recall and said she has no concerns about the safety of the vaccine. As of May 13, Michigan Medicine had administered over 126,000 COVID-19 vaccines with no signs of slowing down. U-M students have also expressed minimal concern about the recall of J&J or campus vaccination requirements. ![]() Additionally, a Kaiser Family Foundation poll found that only 18% of Hispanic women, 11% of Black men and 7% of white women said the news regarding the TTS cases made them less likely to get vaccinated. All of them were individuals who had recently received the J&J vaccine, and three patients died as a result.Ĭampus community remains confident in Johnson and Johnson vaccine safetyĪlthough there were concerns regarding the J&J vaccine’s safety after the recall, a national poll conducted by the de Beaumont Foundation reported that 76% of those surveyed were just as likely to get a COVID-19 vaccine as they were before the pause. On that same day, the FDA and CDC put out an additional statement lifting the pause on the J&J vaccine, publicly reaffirming that it is both safe and effective.Īs of May 14, including the six reported cases before the pause, there have been 28 total confirmed cases of TTS - six of them males. The University said students are considered fully vaccinated two weeks after receiving a single dose vaccine - like J&J - or two weeks after receiving the second shot in a two-dose vaccine series. On April 23, Martino Harmon, vice president of student life, announced that being fully vaccinated against COVID-19 would be required for all students living in on-campus housing for the Fall 2021 semester. Less than a week before the recommended pause of the J&J vaccine, University President Mark Schlissel sent out an email to the campus community announcing that 7,500 doses of the J&J vaccine would be available for students to receive at locations across the three University of Michigan campuses at no cost.Īfter the recall was announced, student appointments for the J&J vaccine were either switched to Pfizer vaccine or cancelled altogether. The single required shot makes administration and distribution easier for communities with limited access to health resources and may be more attractive to individuals with needle anxiety or busy schedules. Unlike the Pfizer and Moderna vaccinations, the J&J vaccination does not need to be stored at sub-zero temperatures and is administered in one shot rather than two. ![]() The J&J vaccine is currently only approved for those 18 and over and was reported as 66.3% effective in clinical trials at preventing COVID-19 two weeks after vaccination, compared to Pfizer and Moderna, which were 95% and 94.1% effective respectively.ĭespite the lower efficacy, the J&J vaccine was 100% effective in trials against hospitalizations and death from COVID-19. The J&J vaccine is one of three CDC-authorized and recommended COVID-19 vaccinations, along with the Pfizer and Moderna vaccines. By the time the vaccine had been brought to a halt, 6.8 million doses of the vaccine had already been administered in the U.S. The Food and Drug Administration and Centers for Disease Control and Prevention issued a joint statement on April 13, recommending an immediate pause on administering the Johnson and Johnson/Janssen COVID-19 vaccine “out of an abundance of caution.” The ensuing 11-day pause was a result of six reported cases in which women ranging from 18 to 48 years of age experienced severe blood clots - a new condition known as thrombosis with thrombocytopenia syndrome (TTS) - less than two weeks after receiving the Johnson and Johnson vaccine.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |